Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
No point getting wound up over rampers.
Over excited fly by nights will come out with various non sequiturs none of which are ironically half as exciting as the probable truth.
Which is that we are likely a few months away from results which could rock medical science.
Very few are yet aware of AVCT's potential. A poster on another board I enjoy reading wondered how much of our valuation is due to sentiment!
Well I can tell him.....
The extremely low valuation is significantly due to AIM sentiment and AIM ignorance.
When you think of it most of us who don't do this for a living have no time to fully research more than two or three shares. It shows!
Someone on this board (who I respect) described us as a high risk share.
Nothing could be further from the truth.
OK there is an element of risk with every single investment opportunity.
We could put our money in Premium Bonds and loose out due to inflation.
You could argue that it is high risk to go all in on ANY investment but that's different from characterising a particular investment as high risk.
Look at the wealth of science behind our pro drug programme.
Look at who is attaching ourselves to our bandwagon
Then sleep well wait patiently. imo if rampers and derampers want to have a ding dong its because the real wonder of whats probably to come is escaping them.
ahem...…
see mine of 8.45 this morning.
Just call me Mystic Meg.
I may as well milk it since its the first prediction I've ever got right
Looks like we are treading the same path as yesterday.
135- 137 close anyone?
I'm no chartist but to me the fact we keep on rising without any real retrace to speak of is a testament to the steadily growing (and justified) positive sentiment surrounding our company.
Still of course ridiculously under valued.
What a relief to be contemplating another few bounces off 1.37
I'll bite since its a quiet day Wyn.
Based on your posts today you consider our chat board to be
irrelevant
an echo chamber
not populated by serious investors
characterised by drivel and anonymous unsupported rants
a fantasy world
making no material difference to the stocks price.
Your posts are also the two longest posts of the day.
After all simply repeating what the company has said and making appropriate inferences a la Energy's iconic post lead us to making statements that on most other BB's would have naysayers crying "Foul".
Imo we are in a very comfortable position as AVCT investors as we share the near and long term confidence which AVCT has expressed.
I see the above company have an RNS today to the effect that winding up proceedings are in contemplation.
Their name is Jupiter Emerging & Fronteir Income Trust plc.
Are they anything to do with our Jupiter?
At the moment the main SP driver is our precision therapeutics programme.
This RNS is a reminder if one were needed of the latent Power of the Affimer which proudly bestrides both our therapeutics programme and is the foundation of our "powerful" diagnostics programme.
There are so many ways forward for AVCT that one of the hardest things for AVCT must have been choosing which world beating strategy to run with.
Our partners look thus far as though they have been extremely well chosen.
At the moment the main SP driver is our precision therapeutics programme.
This RNS is a reminder if one were needed of the latent Power of the Affimer which proudly bestrides both our therapeutics programme and is the foundation of our "powerful" diagnostics programme.
There are so many ways forward for AVCT that one of the hardest things for AVCT must have been choosing which world beating strategy to run with.
Our partners look thus far as though they have been extremely well chosen.
Hey there
Wake up
The share price is going up..............
And theres no ramping or deramping
Call yourselves a decent chatboard..........
Someone give me something to get cross about!!!!!!!
Cancer Tick
Immune Disease Tick
Anything at all antibodies can do but better...…….eg arthritis Chrones Transplants Blood Tranfusions ? Look at what Leeds Uni are imagining for affimers in the future.
I'm convinced its only a matter of time before Avacta can make me irresistible to women!!
Well then!
The rerate was always going to start the only question being when.
No reason now why it won't keep rising into the summer and the sp has a long long way to go.
imo take your seats on the train
You don't want to be left standing on the platform
LFT not abandoned (in fact making good progress)
SP hasn't crashed (in fact on the up)
Therapeutics as expected.
Now all we need to do is sit back and luxuriate in a triumphant Prezzo from Al.
What could possibly go wrong!!
We're more than half way to 1.37
Yaay!
Hi Wiggly
I agree with your post.
I don't think we need to scramble around for justification for our belief that things are going well so far on the AVA6000 trial.
This is not a trial (as so many are) where everyone (including the company) is unaware of how things are going until the results are eventually revealed at the end.
As we know the company (and the committee meeting weekly to monitor the trial and regulate the dosage) are aware on an ongoing basis of the fruits of this data rich trial.
Therefor comments from the company that things are going well next week are a whole lot more than bland remarks.
I'm not expecting any word on efficacy next week because that's not what we're presently addressing but the first time that efficacy is formally addressed even if its not till the summer......I expect shareprice fireworks!
Cautious types are entitled to their view that we should still be aware of the risks but in my laymans opinion the risk/reward profile from here is ridiculously skewed towards reward.
In the US imo we would easily be valued (even as things stand at present) at multiples of where the share price currently stands
"The efficacy and tolerability profile of AVA6000 strongly support its clinical development"
Is it US...……...
For me yesterdays price action (or lack of it) was encouraging.
We seem not to be the traders dream share any more.
Can only be good for us LTH.
……..and diagnostics.